16 related articles for article (PubMed ID: 38606779)
1. In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.
Novetsky AP; Keller MJ; Gradissimo A; Chen Z; Morgan SL; Xue X; Strickler HD; Fernández-Romero JA; Burk R; Einstein MH
Gynecol Oncol; 2016 Nov; 143(2):313-318. PubMed ID: 27625046
[TBL] [Abstract][Full Text] [Related]
2. Safety of carrageenan-based gels as preventive microbicides: a narrative review.
Laurie C; El-Zein M; Franco E
Sex Transm Infect; 2024 Jun; ():. PubMed ID: 38849206
[TBL] [Abstract][Full Text] [Related]
3. Design and methods for the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) study: A randomized controlled trial.
Laurie C; Tota JE; El-Zein M; Tellier PP; Coutlée F; Burchell AN; Franco EL
Contemp Clin Trials; 2021 Nov; 110():106560. PubMed ID: 34487919
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.
Magnan S; Tota JE; El-Zein M; Burchell AN; Schiller JT; Ferenczy A; Tellier PP; Coutlée F; Franco EL;
Clin Microbiol Infect; 2019 Feb; 25(2):210-216. PubMed ID: 29684633
[TBL] [Abstract][Full Text] [Related]
5. Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men.
Kassam P; El-Zein M; Laurie C; Tota JE; Tellier PP; Coutlée F; de Pokomandy A; Franco EL
J Med Virol; 2024 Mar; 96(3):e29562. PubMed ID: 38528834
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a self-applied carrageenan-based gel to prevent human papillomavirus infection in sexually active young women (CATCH study): an exploratory phase IIB randomised, placebo-controlled trial.
Laurie C; El-Zein M; Botting-Provost S; Tota JE; Tellier PP; Coutlée F; Burchell AN; Franco EL
EClinicalMedicine; 2023 Jun; 60():102038. PubMed ID: 37396806
[TBL] [Abstract][Full Text] [Related]
7. Changes in type-specific human papillomavirus load predict progression to cervical cancer.
Depuydt CE; Criel AM; Benoy IH; Arbyn M; Vereecken AJ; Bogers JJ
J Cell Mol Med; 2012 Dec; 16(12):3096-104. PubMed ID: 22978795
[TBL] [Abstract][Full Text] [Related]
8. Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial.
Laurie C; El-Zein M; Tota JE; Tellier PP; Coutlée F; Burchell AN; Franco EL
J Med Virol; 2024 Apr; 96(4):e29604. PubMed ID: 38606779
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
